HemoCue is a global leader in a field of diagnostics known as near patient, or point-of-care, testing. In 1982, HemoCue AB, based in Ängelholm, Sweden, introduced the first system making accurate hemoglobin testing possible in near-patient settings. Since then, more than 350,000 HemoCue systems have been sold worldwide. The company also sells point-of-care tests for glucose, urine albumin, HbA1c, total and differential white blood cell count. HemoCue subsidiaries, affiliates, franchises, and third-party distributors generate revenue in more than 130 countries world wide. HemoCue was acquired by Radiometer, a Danaher company, in April 2013.
HemoCue® and TELCOR Partner to Provide End-to-End Data Management Solutions
PRESS RELEASE 2005-07 HemoCue® announced the availability of full LIS/HIS connectivity for its 201 DM point-of-care testing...
Page 4 of 4